Skip to main content
NVDA-2.58%AAPL+2.84%GOOGL+0.40%MSFT-0.08%AMZN-0.18%TSM-1.36%SPCX+1.02%AVGO-0.60%META-1.19%TSLA-0.50%SKHY-3.99%MU-4.36%BRK-B-0.22%LLY-0.03%JPM-0.59%WMT+0.02%AMD-3.19%V-0.26%XOM+0.65%ASMLa-1.66%JNJ-0.04%INTC-4.60%MA-0.59%0700.HK-1.94%1398.HK+0.79%ORCL-4.06%ABBV+0.98%BAC-0.45%CSCO-1.10%CVX-0.34%COST-0.10%KO+0.56%LRCX-4.91%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.82%HSBA.L-1.30%DELL-3.70%PG+0.43%MS-1.07%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.83%0939.HK+1.66%GS-1.16%NZDJPY-2.61%AUDJPY-1.81%CHFJPY-1.59%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.41%GBPNZD+1.38%GBPJPY-1.24%USDJPY-1.23%EURJPY-1.21%CADJPY-1.16%NZDCHF-1.05%USDZAR+1.00%USDNOK+0.87%USDSEK+0.87%EURZAR+0.85%AUDNZD+0.83%GBPZAR+0.75%EURNOK+0.71%EURSEK+0.71%AUDCAD-0.69%USDTHB+0.65%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.59%GBPAUD+0.56%CHFSEK+0.55%CHFNOK+0.54%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.42%USDPLN+0.42%CADCHF+0.42%GBPTRY+0.41%EURCHF+0.38%USDCHF+0.38%NOKJPY-0.35%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.26%USDSGD+0.26%SGDJPY+0.25%AUDCHF-0.22%NZDMXN-0.22%EURHKD-0.16%USDILS+0.16%USDDKK+0.16%USDTRY+0.11%EURSGD+0.11%GBPCAD-0.10%USDCNH+0.10%PLNJPY+0.09%AUDNOK+0.07%CHFSGD-0.06%USDCAD-0.05%EURGBP+0.05%EURCAD-0.05%EURCZK-0.05%EURCNH-0.04%USDCOP-0.04%GBPUSD-0.02%USDHKD+0.02%EURUSD+0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.09%XAGUSD-5.16%GAGUSD-5.16%UKOIL+5.08%HG1-4.91%USOIL+4.88%XNGUSD+1.70%XAUUSD-1.57%GAUUSD-1.57%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.49%ETHUSD-0.26%USDTUSD-0.02%XRPUSD-3.26%SOLUSD-2.02%TRXUSDT+0.18%ZECUSDT-9.69%DOGEUSD-2.91%XMRUSDT-0.04%LINKUSD-1.47%XLMUSD-1.56%BCHUSDT-10.23%LTCUSD-1.77%UNIUSD-1.50%TONUSD+24.88%HBARUSDT-2.42%SUIUSD-4.27%TAOUSDT-5.36%AAVEUSD-2.45%DOTUSDT-1.65%ICPUSDT-1.22%ONDOUSDT-3.31%WLDUSDT-3.39%ATOMUSDT-3.62%ARBUSDT+0.14%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.27%TIAUSDT-1.13%PYTHUSDT-1.53%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.87%OPUSDT-3.00%POLUSDT-4.63%IOTAUSDT-3.71%AXSUSDT-2.36%FARTCOINUSDT-4.10%EOSUSDT-2.78%DYDXUSDT-2.24%ORDIUSDT-0.75%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.58%AAPL+2.84%GOOGL+0.40%MSFT-0.08%AMZN-0.18%TSM-1.36%SPCX+1.02%AVGO-0.60%META-1.19%TSLA-0.50%SKHY-3.99%MU-4.36%BRK-B-0.22%LLY-0.03%JPM-0.59%WMT+0.02%AMD-3.19%V-0.26%XOM+0.65%ASMLa-1.66%JNJ-0.04%INTC-4.60%MA-0.59%0700.HK-1.94%1398.HK+0.79%ORCL-4.06%ABBV+0.98%BAC-0.45%CSCO-1.10%CVX-0.34%COST-0.10%KO+0.56%LRCX-4.91%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.37%UNH-0.82%HSBA.L-1.30%DELL-3.70%PG+0.43%MS-1.07%GE-0.69%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.15%HD-1.83%0939.HK+1.66%GS-1.16%NZDJPY-2.61%AUDJPY-1.81%CHFJPY-1.59%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.41%GBPNZD+1.38%GBPJPY-1.24%USDJPY-1.23%EURJPY-1.21%CADJPY-1.16%NZDCHF-1.05%USDZAR+1.00%USDNOK+0.87%USDSEK+0.87%EURZAR+0.85%AUDNZD+0.83%GBPZAR+0.75%EURNOK+0.71%EURSEK+0.71%AUDCAD-0.69%USDTHB+0.65%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.59%GBPAUD+0.56%CHFSEK+0.55%CHFNOK+0.54%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.42%USDPLN+0.42%CADCHF+0.42%GBPTRY+0.41%EURCHF+0.38%USDCHF+0.38%NOKJPY-0.35%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%EURPLN+0.26%USDSGD+0.26%SGDJPY+0.25%AUDCHF-0.22%NZDMXN-0.22%EURHKD-0.16%USDILS+0.16%USDDKK+0.16%USDTRY+0.11%EURSGD+0.11%GBPCAD-0.10%USDCNH+0.10%PLNJPY+0.09%AUDNOK+0.07%CHFSGD-0.06%USDCAD-0.05%EURGBP+0.05%EURCAD-0.05%EURCZK-0.05%EURCNH-0.04%USDCOP-0.04%GBPUSD-0.02%USDHKD+0.02%EURUSD+0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.09%XAGUSD-5.16%GAGUSD-5.16%UKOIL+5.08%HG1-4.91%USOIL+4.88%XNGUSD+1.70%XAUUSD-1.57%GAUUSD-1.57%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.49%ETHUSD-0.26%USDTUSD-0.02%XRPUSD-3.26%SOLUSD-2.02%TRXUSDT+0.18%ZECUSDT-9.69%DOGEUSD-2.91%XMRUSDT-0.04%LINKUSD-1.47%XLMUSD-1.56%BCHUSDT-10.23%LTCUSD-1.77%UNIUSD-1.50%TONUSD+24.88%HBARUSDT-2.42%SUIUSD-4.27%TAOUSDT-5.36%AAVEUSD-2.45%DOTUSDT-1.65%ICPUSDT-1.22%ONDOUSDT-3.31%WLDUSDT-3.39%ATOMUSDT-3.62%ARBUSDT+0.14%JUPUSDT-3.82%INJUSDT-2.88%STXUSDT-4.16%FETUSDT-3.27%TIAUSDT-1.13%PYTHUSDT-1.53%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.37%WIFUSDT-5.87%OPUSDT-3.00%POLUSDT-4.63%IOTAUSDT-3.71%AXSUSDT-2.36%FARTCOINUSDT-4.10%EOSUSDT-2.78%DYDXUSDT-2.24%ORDIUSDT-0.75%GALAUSDT-3.65%NOTUSDT-2.97%RONINUSDT-2.64%
AO

Aktis Oncology, Inc. (AKTS)

NASDAQ • Healthcare

$24.06
-$0.96 (-3.8%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$25.57
Previous Close$24.06
Day Range$24.03 - $26
Avg. Volume (3M)287.8K
Market Cap$1.2B
52 Week Range
$14.72$34.19
Next EarningsIn 63 daysNov 12, 2026

Metrics Over Time

Where the Money Goes

Q4 2025
Revenueeverything earned$6.4M100%
Gross Profitminus cost of goods$6.4M100%

Fundamentals & Financials

Revenue (TTM)
$10M
Net Income (TTM)
-$73.1M
EPS (TTM)
-$1.05
ROA (TTM)
-13.12%
Current Ratio
7.37

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+15.8%Q1 2026-$18.19
-22.6%Q2 2026-$0.38
-2.2%Q3 2026-$0.44
Next

Nov 12

in 63 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Aktis Oncology, Inc.

Aktis Oncology, Inc. is a NASDAQ-listed healthcare company in biotechnology that develops targeted radiopharmaceutical therapies for cancer treatment. It operates as a clinical-stage biotech business rather than a commercial drug seller, with work centered on a proprietary miniprotein radioconjugate platform designed to create tumor-seeking medicines.

Name
Aktis Oncology, Inc.
CEO
Matthew Roden
Website
www.aktisoncology.com
Industry
Healthcare
Year Founded
2020
Employees
79

Today's Snapshot

AI-generated

So far today, AKTS is trading 1.8% lower at 23.62, while its sector was flat. Oppenheimer, an investment bank, began covering Aktis Oncology and said its shares should beat the market.

Trading Volume

Below 10d avg (255.7K)

78.6K

vs S&P 500 Today

Underperforming Market

-1.27%

Updated: September 10, 2026 at 16:37 UTC

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.